New SPECT/MR holds promise for a variety of clinical uses

06/13/2013 | Diagnostic Imaging

SPECT/MR was introduced at an imaging meeting as a flexible preclinical molecular imaging approach that could deliver improved resolution and lower radiation dose. Possible indications include imaging for cardiovascular and neurological disease, cancer, endocrine disorders and much more. Experts including Benjamin Tsui have developed the technology with TriFoil Imaging, and Tsui said human trials are on the horizon in the next couple of years.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX